photo
M Aapro

Multidisciplinary Institute of Oncology, Genolier, Switzerland.


1
Matti Aapro, Jindrich Finek “Oral vinorelbine in metastatic breast cancer: a review of current clinical trial results.”, Cancer Treat. Rev., vol. 38, no. 2, 2012
View At Pubmed
2
Matti S Aapro, Robert E Coleman “Bone health management in patients with breast cancer: current standards and emerging strategies.”, Breast, vol. 21, no. 1, 2012
View At Pubmed
3
M S Aapro “What do prescribers think of biosimilars?”, Target Oncol, vol. 7 Suppl 1, 2012
View At Pubmed
4
M Aapro, W Jelkmann, S N Constantinescu, B Leyland-Jones “Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.”, Br. J. Cancer, vol. 106, no. 7, 2012
View At Pubmed
5
M Aapro, A Molassiotis, M Dicato, I Peláez, Á Rodríguez-Lescure, D Pastorelli, L Ma, T Burke, A Gu, P Gascon, F Roila, “The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).”, Ann. Oncol., vol. 23, no. 8, 2012
View At Pubmed
6
M Aapro, A Österborg, P Gascón, H Ludwig, Y Beguin “Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron.”, Ann. Oncol., vol. 23, no. 8, 2012
View At Pubmed
7
M Aapro “Emerging topics in anaemia and cancer.”, Ann. Oncol., vol. 23 Suppl 10, 2012
View At Pubmed
8
M Aapro, H Wildiers “Triple-negative breast cancer in the older population.”, Ann. Oncol., vol. 23 Suppl 6, 2012
View At Pubmed
9
Matti S Aapro “Management of advanced prostate cancer in senior adults: the new landscape.”, Oncologist, vol. 17 Suppl 1, 2012
View At Pubmed
10
Matti Aapro, Vincent Launay-Vacher “Importance of monitoring renal function in patients with cancer.”, Cancer Treat. Rev., vol. 38, no. 3, 2012
View At Pubmed
11
Matti Aapro, Sergei Tjulandin, Paul Bhar, William Gradishar “Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysis.”, Breast, vol. 20, no. 5, 2011
View At Pubmed
12
Matti Aapro, Matthias Schwenkglenks, Gary H Lyman, Antonio Lopez Pousa, Susan Lawrinson, Tomas Skacel, Pamela Bacon, Gunter von Minckwitz “Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy.”, Crit. Rev. Oncol. Hematol., vol. 74, no. 3, 2010
View At Pubmed
13
M Aapro, A Fabi, F Nolè, M Medici, G Steger, C Bachmann, S Roncoroni, F Roila “Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.”, Ann. Oncol., vol. 21, no. 5, 2010
View At Pubmed
14
Matti Aapro, Jeffrey Crawford, Didier Kamioner “Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?”, Support Care Cancer, vol. 18, no. 5, 2010
View At Pubmed
15
M S Aapro, C M Walko “Aprepitant: drug-drug interactions in perspective.”, Ann. Oncol., vol. 21, no. 12, 2010
View At Pubmed
16
Matti S Aapro “Challenges in clinical patient management.”, Cancer Invest., vol. 28 Suppl 1, 2010
View At Pubmed
17
Matti Aapro, Fred Saad, Luis Costa “Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.”, Oncologist, vol. 15, no. 11, 2010
View At Pubmed
18
M S Aapro, J Bohlius, D A Cameron, Lissandra Dal Lago, J Peter Donnelly, N Kearney, G H Lyman, R Pettengell, V C Tjan-Heijnen, J Walewski, Damien C Weber, C Zielinski, “2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.”, Eur. J. Cancer, vol. 47, no. 1, 2010
View At Pubmed
19
Matti S Aapro “[Oncology].”, Rev Med Suisse, vol. 5, no. 189, 2009
View At Pubmed
20
Matti Aapro “An update on twenty years of anemia management with erythropoiesis-stimulating agents in nephrology and oncology/hematology.”, Oncologist, vol. 14 Suppl 1, 2009
View At Pubmed
21
Matti Aapro, Jerry L Spivak “Update on erythropoiesis-stimulating agents and clinical trials in oncology.”, Oncologist, vol. 14 Suppl 1, 2009
View At Pubmed
22
M Aapro, Silvio Monfardini, Antonio Jirillo, Umberto Basso “Management of primary and advanced breast cancer in older unfit patients (medical treatment).”, Cancer Treat. Rev., vol. 35, no. 6, 2009
View At Pubmed
23
Matti Aapro, Agustí Barnadas, Robert C Leonard, Maurizio Marangolo, Michael Untch, Lidia Ukarma, Hans-Ulrich Burger, Armin Scherhag, Bruno Osterwalder “What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?”, Eur. J. Cancer, vol. 45, no. 17, 2009
View At Pubmed
24
M Aapro, B Osterwalder, A Scherhag, H U Burger “Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events.”, Br. J. Cancer, vol. 101, no. 12, 2009
View At Pubmed
25
Matti Aapro, Ivo Abraham, Carsten Bokemeyer, Heinz Ludwig, Karen Macdonald, Pierre Soubeyran, Matthew Turner “The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.”, Support Care Cancer, vol. 16, no. 2, 2008
View At Pubmed
26
M Aapro, P A Abrahamsson, J J Body, R E Coleman, R Colomer, L Costa, L Crinò, L Dirix, M Gnant, J Gralow, P Hadji, G N Hortobagyi, W Jonat, A Lipton, A Monnier, A H G Paterson, R Rizzoli, F Saad, B Thürlimann “Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.”, Ann. Oncol., vol. 19, no. 3, 2008
View At Pubmed
27
Matti Aapro, Robert C Leonard, Agustí Barnadas, Maurizio Marangolo, Michael Untch, Nikolaos Malamos, José Mayordomo, Dietmar Reichert, José Luiz Pedrini, Lidia Ukarma, Armin Scherhag, Hans-Ulrich Burger “Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.”, J. Clin. Oncol., vol. 26, no. 4, 2008
View At Pubmed
28
M S Aapro “[Medical oncology trends].”, Rev Med Suisse, vol. 4, no. 140, 2008
View At Pubmed
29
Matti S Aapro, Hartmut Link “September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.”, Oncologist, vol. 13 Suppl 3, 2008
View At Pubmed
30
Matti S Aapro “Palonosetron as an anti-emetic and anti-nausea agent in oncology.”, Ther Clin Risk Manag, vol. 3, no. 6, 2008
View At Pubmed
31
M Aapro, A Scherhag, H U Burger “Effect of treatment with epoetin-beta on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients.”, Br. J. Cancer, vol. 99, no. 1, 2008
View At Pubmed
32
Matti S Aapro “Management of bisphosphonate treatment in clinical practice.”, Semin. Oncol., vol. 34, no. 6 Suppl 4, 2007
View At Pubmed
33
M S Aapro “[Medical oncology].”, Rev Med Suisse, vol. 3, no. 93, 2007
View At Pubmed
34
Matti S Aapro, Pierfranco Conte, Emilio Esteban González, Véronique Trillet-Lenoir “Oral vinorelbine: role in the management of metastatic breast cancer.”, Drugs, vol. 67, no. 5, 2007
View At Pubmed
35
M S Aapro “[Medical oncology].”, Rev Med Suisse, vol. 2, no. 48, 2006
View At Pubmed
36
M Aapro “Improving bone health in patients with early breast cancer by adding bisphosphonates to letrozole: the Z-ZO-E-ZO-FAST program.”, Breast, vol. 15 Suppl 1, 2006
View At Pubmed
37
M S Aapro, D A Cameron, R Pettengell, J Bohlius, J Crawford, M Ellis, N Kearney, G H Lyman, V C Tjan-Heijnen, J Walewski, D C Weber, C Zielinski, “EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.”, Eur. J. Cancer, vol. 42, no. 15, 2006
View At Pubmed
38
M Aapro, B Coiffier, J Dunst, A Osterborg, H U Burger “Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysis.”, Br. J. Cancer, vol. 95, no. 11, 2006
View At Pubmed
39
Matti S Aapro, Alexander Molassiotis, Ian Olver “Anticipatory nausea and vomiting.”, Support Care Cancer, vol. 13, no. 2, 2005
View At Pubmed
40
M S Aapro “[Medical oncology].”, Rev Med Suisse, vol. 1, no. 1, 2005
View At Pubmed
41
Matti S Aapro, Claus-Henning Köhne, Harvey Jay Cohen, Martine Extermann “Never too old? Age should not be a barrier to enrollment in cancer clinical trials.”, Oncologist, vol. 10, no. 3, 2005
View At Pubmed
42
Matti Aapro, Peter Blower “5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?”, Cancer, vol. 104, no. 1, 2005
View At Pubmed
43
Matti Aapro “Optimising antiemetic therapy: what are the problems and how can they be overcome?”, Curr Med Res Opin, vol. 21, no. 6, 2005
View At Pubmed
44
Matti Aapro, Judi Johnson “Chemotherapy-induced emesis in elderly cancer patients: the role of 5-HT3-receptor antagonists in the first 24 hours.”, Gerontology, vol. 51, no. 5, 2005
View At Pubmed
45
Matti Aapro “5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment.”, Oncology, vol. 69, no. 2, 2005
View At Pubmed
46
Matti S Aapro, Alberto Macciocchi, Cesare Gridelli “Palonosetron improves prevention of chemotherapy-induced nausea and vomiting in elderly patients.”, J Support Oncol, vol. 3, no. 5, 2005
View At Pubmed
47
Matti Aapro, Jésus San Miguel “Evolving treatment strategies for anaemia in cancer: experience with epoetin beta.”, Oncology, vol. 67 Suppl 1, 2004
View At Pubmed
48
Matti Aapro “Granisetron: an update on its clinical use in the management of nausea and vomiting.”, Oncologist, vol. 9, no. 6, 2004
View At Pubmed
49
Matti S Aapro “Long-term implications of bone loss in breast cancer.”, Breast, vol. 13 Suppl 1, 2004
View At Pubmed
Keywords
 administration & dosage  adverse effects  Albumins  analogs & derivatives  analysis  Anemia  Anemia, Hypochromic  Anemia, Iron-Deficiency  Antiemetics  Antineoplastic Agents  Antineoplastic Agents, Phytogenic  Antineoplastic Combined Chemotherapy Protocols  Aromatase Inhibitors  Biological Agents  blood  Bone Density Conservation Agents  Bone Neoplasms  Bone Resorption  Breast Neoplasms  chemically induced  Clinical Trials as Topic  Colorectal Neoplasms  complications  Dexamethasone  Diphosphonates  Drug Administration Schedule  Drug Prescriptions  drug therapy  Drugs, Generic  Eligibility Determination  Erythropoietin  ethics  etiology  Fever  Fibrinolytic Agents  Granisetron  Granulocyte Colony-Stimulating Factor  Guideline Adherence  Hematinics  Hematologic Diseases  Hemoglobins  Imidazoles  Iron Compounds  Isoquinolines  Kidney Diseases  Kidney Function Tests  Lung Neoplasms  Lymphoproliferative Disorders  Medical Oncology  Morpholines  mortality  Nausea  Neoplasms  Neutropenia  Nitriles  Osteoporosis  Osteoporosis, Postmenopausal  Paclitaxel  pathology  pharmacokinetics  pharmacology  Physician's Practice Patterns  physiology  physiopathology  Practice Guidelines as Topic  prevention & control  Prostatic Neoplasms  Quinuclidines  radiotherapy  Receptors, Serotonin, 5-HT3  secondary  Serotonin 5-HT3 Receptor Antagonists  Serotonin Antagonists  standards  statistics & numerical data  therapeutic use  therapy  Thromboembolism  Thrombosis  trends  Triazoles  Vinblastine  Vomiting  Vomiting, Anticipatory  World Health

No Biography Available.